Arrivo BioVentures
PrivateLast Round
Series B
Nov 29, 2023
Total Funding Raised
$45.25M
Company Overview
Arrivo BioVentures is a biopharmaceutical company that develops first-of-its-kind medicines targeting the root causes of hard-to-treat diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Arrivo BioVentures Comparables
Compare Arrivo BioVentures with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Retromer Therapeutics | 76% | |
| Apollo Therapeutics | 70% | |
| ApoGlyx | 66% |
Arrivo BioVentures Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Nov 29, 2023 | ||||
| VC Round | May 25, 2016 |
Arrivo BioVentures Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Orlando Health Ventures | Series B |
| Solas BioVentures | VC Round, Series B |
| Rex Health Ventures | VC Round, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 16, 2026
Monthly visitors increased 31% MoM.
- Nov 29, 2023
$45.25M round led by Orlando Health Ventures
Arrivo BioVentures Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Arrivo BioVentures's valuation, stock price, and market status.
Is Arrivo BioVentures a public or private company?
Arrivo BioVentures is a private company.
What is the current stock price of Arrivo BioVentures?
Arrivo BioVentures is a private company with no public stock price. No recent secondary market data is available.
How much is Arrivo BioVentures worth (valuation)?
Valuation information for Arrivo BioVentures is not publicly available.
Can I buy Arrivo BioVentures stock?
Arrivo BioVentures shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Arrivo BioVentures's last funding round?
Arrivo BioVentures's most recent funding round was Series B on November 29, 2023.
Who are the main investors in Arrivo BioVentures?
Key investors in Arrivo BioVentures include Orlando Health Ventures.
Will Arrivo BioVentures IPO soon?
No public IPO plans have been announced for Arrivo BioVentures.
How can I track Arrivo BioVentures secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Arrivo BioVentures's secondary market activity and sign up for updates.